The effect of lidocaine on lysophosphatidylcholine-induced cardiac arrhythmias and cellular disturbances

K. J. Neufeld, C. L. Lederman, P. C. Choy, R. Y.K. Man

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The production of arrhythmias in the isolated heart by perfusion with lysophosphatidylcholine has been well documented. However, the role of the lysophospholipid as a physiological factor in the generation of cardiac arrhythmias is not clear. In this study, a pharmacological approach was used to delineate the physiological significance of lysophosphatidylcholine during this cardiac dysfunction. Lidocaine (5-20 mg/L) was found to be effective in the protection of the isolated rat heart from the lysophospholipid-induced arrhythmias at pharmacological concentrations. The effect of lidocaine in the protection of lysophospholipid-induced membrane dysfunction was studied with red blood cells. Lidocaine (2 mg/L) protected red blood cells from hemolysis in the presence of lysophosphatidylcholine. Lidocaine did not inhibit the binding of the lysophospholipid to the red cell membrane, but inhibited hemolysis in a manner similar to cholesterol. The results are consistent with the postulate that lysophosphatidylcholine is a physiological factor in the pathogenesis of cardiac arrhythmias during myocardial ischemia.

Original languageEnglish (US)
Pages (from-to)804-808
Number of pages5
JournalCanadian Journal of Physiology and Pharmacology
Issue number7
StatePublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)


Dive into the research topics of 'The effect of lidocaine on lysophosphatidylcholine-induced cardiac arrhythmias and cellular disturbances'. Together they form a unique fingerprint.

Cite this